Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Using Telemetry Data to Refine Endpoints for New Zealand White Rabbits Challenged with Bacillus anthracis.

Dawson DG, Bower KA, Burnette CN, Holt RK, Swearengen JR, Dabisch PA, Scorpio A.

J Am Assoc Lab Anim Sci. 2017 Nov 1;56(6):792-801.

2.

Quantification of regional aerosol deposition patterns as a function of aerodynamic particle size in rhesus macaques using PET/CT imaging.

Dabisch PA, Xu Z, Boydston JA, Solomon J, Bohannon JK, Yeager JJ, Taylor JR, Reeder RJ, Sayre P, Seidel J, Mollura DJ, Hevey MC, Jahrling PB, Lackemeyer MG.

Inhal Toxicol. 2017 Sep;29(11):506-515. doi: 10.1080/08958378.2017.1409848. Epub 2017 Dec 11.

PMID:
29224407
3.

Prophylaxis with human serum butyrylcholinesterase protects Göttingen minipigs exposed to a lethal high-dose of sarin vapor.

Saxena A, Hastings NB, Sun W, Dabisch PA, Hulet SW, Jakubowski EM, Mioduszewski RJ, Doctor BP.

Chem Biol Interact. 2015 Aug 5;238:161-9. doi: 10.1016/j.cbi.2015.07.001. Epub 2015 Jul 3.

PMID:
26145887
4.

A characterization of aerosolized Sudan virus infection in African green monkeys, cynomolgus macaques, and rhesus macaques.

Zumbrun EE, Bloomfield HA, Dye JM, Hunter TC, Dabisch PA, Garza NL, Bramel NR, Baker RJ, Williams RD, Nichols DK, Nalca A.

Viruses. 2012 Oct 15;4(10):2115-36. doi: 10.3390/v4102115.

5.

Natural history of inhalation melioidosis in rhesus macaques (Macaca mulatta) and African green monkeys (Chlorocebus aethiops).

Yeager JJ, Facemire P, Dabisch PA, Robinson CG, Nyakiti D, Beck K, Baker R, Pitt ML.

Infect Immun. 2012 Sep;80(9):3332-40. doi: 10.1128/IAI.00675-12. Epub 2012 Jul 9.

6.

Pretreatment with human serum butyrylcholinesterase alone prevents cardiac abnormalities, seizures, and death in Göttingen minipigs exposed to sarin vapor.

Saxena A, Sun W, Dabisch PA, Hulet SW, Hastings NB, Jakubowski EM, Mioduszewski RJ, Doctor BP.

Biochem Pharmacol. 2011 Dec 15;82(12):1984-93. doi: 10.1016/j.bcp.2011.09.019. Epub 2011 Sep 24.

PMID:
21968035
7.

Characterization of a head-only aerosol exposure system for nonhuman primates.

Dabisch PA, Kline J, Lewis C, Yeager J, Pitt ML.

Inhal Toxicol. 2010 Feb;22(3):224-33. doi: 10.3109/08958370903191023.

PMID:
20063997
8.

Efficacy of human serum butyrylcholinesterase against sarin vapor.

Saxena A, Sun W, Dabisch PA, Hulet SW, Hastings NB, Jakubowski EM, Mioduszewski RJ, Doctor BP.

Chem Biol Interact. 2008 Sep 25;175(1-3):267-72. doi: 10.1016/j.cbi.2008.05.022. Epub 2008 May 23.

PMID:
18597747
9.

Gender difference in the miotic potency of soman vapor in rats.

Dabisch PA, Horsmon MS, Taylor JT, Muse WT, Miller DB, Sommerville DR, Mioduszewski RJ, Thomson S.

Cutan Ocul Toxicol. 2008;27(2):123-33. doi: 10.1080/15569520802064376.

PMID:
18568898
10.

Validation and application of a GC-MS method for determining soman concentration in rat plasma following low-level vapor exposure.

Renner JA, Dabisch PA, Evans RA, McGuire JM, Totura AL, Jakubowski EM, Thomson SA.

J Anal Toxicol. 2008 Jan-Feb;32(1):92-8.

PMID:
18269800
11.

Biomarkers of low-level exposure to soman vapor: comparison of fluoride regeneration to acetylcholinesterase inhibition.

Dabisch PA, Davis EA, Renner JA, Jakubowski EM, Mioduszewski RJ, Thomson SA.

Inhal Toxicol. 2008 Jan;20(2):149-56. doi: 10.1080/08958370701821300 .

PMID:
18236229
12.

Analysis of L-NAME-dependent and -resistant responses to acetylcholine in the rat.

Dabisch PA, Liles JT, Baber SR, Golwala NH, Murthy SN, Kadowitz PJ.

Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H688-98. Epub 2007 Nov 21.

13.

Muscarinic receptor dysfunction induced by exposure to low levels of soman vapor.

Dabisch PA, Horsmon MS, Muse WT, Mioduszewski RJ, Thomson S.

Toxicol Sci. 2007 Nov;100(1):281-9. Epub 2007 Aug 9.

PMID:
17693423
14.

Multiple exposures to sarin vapor result in parasympathetic dysfunction in the eye but not the heart.

Dabisch PA, To F, Kerut EK, Horsmon MS, Mioduszewski RJ.

Toxicol Sci. 2007 Sep;99(1):354-61. Epub 2007 Jun 19.

PMID:
17578861
15.

Development of miotic cross-tolerance between pyridostigmine and sarin vapor.

Dabisch PA, Davis EA, Horsmon MS, Mioduszewski RJ.

J Ocul Pharmacol Ther. 2006 Oct;22(5):323-32.

PMID:
17076626
16.

Effects of whole-body VX vapor exposure on lethality in rats.

Benton BJ, McGuire JM, Sommerville DR, Dabisch PA, Jakubowski EM, Matson KL, Mioduszewski RJ, Thomson SA, Crouse CL.

Inhal Toxicol. 2006 Dec;18(14):1091-9.

PMID:
17050346
17.

Comparison of low-level sarin and cyclosarin vapor exposure on pupil size of the Gottingen minipig: effects of exposure concentration and duration.

Hulet SW, Sommerville DR, Crosier RB, Dabisch PA, Miller DB, Benton BJ, Forster JS, Scotto JA, Jarvis JR, Krauthauser C, Muse WT, Reutter SA, Mioduszewski RJ, Thomson SA.

Inhal Toxicol. 2006 Feb;18(2):143-53.

PMID:
16393929
18.

Effect of binge cocaine treatment on hindlimb vascular function.

Pradhan L, Dabisch PA, Liles JT, Murthy SN, Baber SR, Simpson SA, Agrawal KC, Kadowitz PJ.

J Appl Toxicol. 2005 Nov-Dec;25(6):479-90.

PMID:
16092079
19.

Pressor responses to ephedrine are mediated by a direct mechanism in the rat.

Liles JT, Dabisch PA, Hude KE, Pradhan L, Varner KJ, Porter JR, Hicks AR, Corll C, Baber SR, Kadowitz PJ.

J Pharmacol Exp Ther. 2006 Jan;316(1):95-105. Epub 2005 Jul 7.

PMID:
16002460
20.

Tolerance to the miotic effect of sarin vapor in rats after multiple low-level exposures.

Dabisch PA, Burnett DC, Miller DB, Jakubowski EM, Muse WT, Forster JS, Scotto JA, Jarvis JR, Davis EA, Hulet SW, Reutter SA, Mioduszewski RJ, Thomson SA.

J Ocul Pharmacol Ther. 2005 Jun;21(3):182-95.

PMID:
15969635
21.

Miotic tolerance to sarin vapor exposure: role of the sympathetic and parasympathetic nervous systems.

Dabisch PA, Miller DB, Reutter SA, Mioduszewski RJ, Thomson SA.

Toxicol Sci. 2005 Jun;85(2):1041-7. Epub 2005 Mar 23.

PMID:
15788726
22.

Responses to bradykinin are mediated by NO-independent mechanisms in the rat hindlimb vascular bed.

Dabisch PA, Kerut EK, Liles JT, Wien G, Smith M, Patterson M, McCoul ED, Sears BW, Saenz R, Kadowitz PJ.

Pharmacol Res. 2004 Dec;50(6):575-84.

PMID:
15501695
23.

Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats.

Bivalacqua TJ, Usta MF, Champion HC, Leungwattanakij S, Dabisch PA, McNamara DB, Kadowitz PJ, Hellstrom WJ.

Int J Impot Res. 2004 Feb;16(1):21-9.

PMID:
14963467
24.

Role of potassium channels in the nitric oxide-independent vasodilator response to acetylcholine.

Dabisch PA, Liles JT, Taylor JT, Sears BW, Saenz R, Kadowitz PJ.

Pharmacol Res. 2004 Mar;49(3):207-15.

PMID:
14726215
25.

Peroxynitrite does not impair pulmonary and systemic vascular responses.

Nossaman BD, Dabisch PA, Liles JT, Baber SR, Champion HC, Kaye AD, Feng CJ, Anwar M, Bivalacqua TJ, Santiago JA, De Witt BJ, Kadowitz PJ.

J Appl Physiol (1985). 2004 Feb;96(2):455-62.

26.

Effect of inhibition of nitric oxide synthase on the vasopressor response to ephedrine.

Dabisch PA, Liles JT, Kadowitz PJ.

Can J Physiol Pharmacol. 2003 Oct;81(10):966-71.

PMID:
14608414
27.

Effect of acute intravenous cocaine administration on endothelium-dependent vasodepressor responses to acetylcholine.

Pradhan L, Dabisch PA, Liles JT, Agrawal KC, Kadowitz PJ.

J Cardiovasc Pharmacol Ther. 2003 Mar;8(1):43-51.

PMID:
12652329

Supplemental Content

Loading ...
Support Center